• Written by ajiang
  • June 14, 2010 at 2:14 am
  • Gershon Capital provides advisory services to healthcare and life science companies through its relationship with Gershon & Company, our consulting arm founded in 1999. The Gershon & Company advisory group leverages its senior management team and industry networks to bring sector expertise, investment experience, and regulatory, scientific and medical knowledge to emerging healthcare and life science companies, hedge funds, private equity firms, and government.

    An entire company’s survival may well depend on its ability to develop its intellectual capital. In turn, management and investors depend on the ability of IP legal counsel to defend and protect those IP assets ensuring a company’s vitality and viability. Gershon Capital has the broad legal experience and the specific scientific background to successfully navigate the many challenges members of the biotech industry face. The firm provides world-class litigation services, and approaches all IP matters as potential litigations to be won or avoided. Healthcare and life science companies rely on us to apply this approach in our substantial patent prosecution, licensing, opinion work and counseling practices.

    For more information, contact:

    Kent H. Cheng, JD, Ph. D., Co-Director of Patents and Intellectual Property


    Martin B. Pavane, JD, Co-Director of Patents and Intellectual Property


  • Conference Info:


    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City

    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!